Sperm protein 17: Clinical relevance of a cancer/testis antigen, from contraception to cancer immunotherapy, and beyond

International Reviews of Immunology

Volumn 30, Issue 2-3, 2011, Pages 138-149

  Chiriva Internati, Maurizio ^a,b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Southwest Cancer Treatment and Research Center   (United States)

Author keywords

cancer testis antigens; cell contact; fertility; oncogenesis; ovarian cancer; Sperm protein 17

Indexed keywords

A KINASE ANCHORING PROTEIN 3; AUTOANTIBODY; CANCER TESTIS ANTIGEN; CANCER VACCINE; CISPLATIN; CPG OLIGODEOXYNUCLEOTIDE; DENDRITIC CELL VACCINE; EPITOPE; ERLOTINIB; GELDANAMYCIN; PROTEIN KINASE; RECOMBINANT PROTEIN; SPERM PROTEIN 17; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CANCER INVASION; CARCINOGENESIS; CELL CONTACT; CONTRACEPTION; CYTOTOXIC T LYMPHOCYTE; DRUG TARGETING; ESOPHAGUS CANCER; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; INFERTILITY; INTRACELLULAR SIGNALING; METASTASIS POTENTIAL; MULTIPLE MYELOMA; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SPERMATOZOON MOTILITY; SQUAMOUS CELL CARCINOMA; VASECTOMY;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; AUTOANTIGENS; CARCINOMA; CARRIER PROTEINS; CONTRACEPTION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MICE; OVARIAN NEOPLASMS; SPERMATOZOA; TESTIS;

EID: 79955861307     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.3109/08830185.2011.569903     Document Type: Article

References (73)

1. Chiriva-Internati M, Wang Z, Xue Y, et al. Sperm protein 17 (Sp17) in multiple myeloma: Opportunity for myeloma-Specific donor T cell infusion to enhance graft-versus-myeloma efect without increasing graft-versus-host disease risk. Eur J Immunol 2001;31:2277-2283. (Pubitemid 32785345)
2. Costa FF, Le Blanc K, Brodin B Concise review: Cancer/testis antigens, stem cells, and cancer. Stem Cells 2007;25:707-711. (Pubitemid 46354230)
3. Lacy HM, Sanderson RD Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell-cell adhesion. Blood 2001;98:2160-2165.
4. Chiriva-Internati M, Grizzi F, Bright RK, Martin Kast W Cancer immunotherapy: Avoiding the road to perdition. J Transl Med 2004;2:26.
5. Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: Review, standardization, and commentary. Cancer Immun 2004;4:1.
6. Van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-1647. (Pubitemid 21917508)
7. Gaugler B, Van den Eynde B, Van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-930. (Pubitemid 24065650)
8. Boel P, Wildmann C, Sensi ML, et al. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995;2:167-175.
9. Van den Eynde B, Peeters O, De Backer O, et al. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995;182:689-698.
10. Boon T, Coulie PG, Van den Eynde B Tumor antigens recognized by T cells. Immunol Today 1997;18:267-268. (Pubitemid 27261443)
11. Caballero OL, Chen YT Cancer/testis (CT) antigens: Potential targets for immunotherapy. Cancer Sci 2009;100:2014-2021.
12. Chiriva-Internati M, Gagliano N, Donetti E, et al. Sperm protein 17 is expressed in the sperm fbrous sheath. J Transl Med 2009;7:61.
13. Sahin U, Tureci O, Pfreundschuh M Serological identifcation of human tumor antigens. Curr Opin Immunol 1997;9:709-716. (Pubitemid 27485301)
14. Chen YT, Scanlan MJ, Sahin U, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997;94:1914-1918. (Pubitemid 27113936)
15. Old LJ, Chen YT New paths in human cancer serology. J Exp Med 1998;187:1163-1167. (Pubitemid 28189106)
16. Chiriva-Internati M, Wang Z, Pochopien S, et al. Identifcation of a sperm protein 17 CTL epitope restricted by HLA-A1. Int J Cancer 2003;107:863-865. (Pubitemid 37339743)
17. Chiriva-Internati M, Wang Z, Salati E, et al. Successful generation of sperm protein 17 (Sp17)-Specific cytotoxic T lymphocytes from normal donors: Implication for tumour-Specific adoptive im-munotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma. Scand J Immunol 2002;56:429-433.
18. Lim SH, Wang Z, Chiriva-Internati M, Xue Y Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood 2001;97:1508-1510. (Pubitemid 32183780)
19. Bai S, He B, Wilson EM Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Mol Cell Biol 2005;25:1238-1257. (Pubitemid 40204904)
20. Nagao T, Higashitsuji H, Nonoguchi K, et al. MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem 2003;278:10668-10674. (Pubitemid 36800336)
21. Peikert T, Specks U, Farver C, et al. Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis. Cancer Res 2006;66:4693-4700.
22. Yang B, O'Herrin SM, Wu J, et al. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 2007;67:9954-9962. (Pubitemid 47621245)
23. Cilensek ZM, Yehiely F, Kular RK, Deiss LP A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, Interferon-gamma, taxol and gamma-irradiation. Cancer Biol Ter 2002;1:380-387.
24. Duan Z, Duan Y, Lamendola DE, et al. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin Cancer Res 2003;9:2778-2785. (Pubitemid 36842124)
25. Laduron S, Deplus R, ZhouS, et al. MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription. Nucleic Acids Res 2004;32:4340-4350. (Pubitemid 39232306)
26. Zhou S, Fujimuro M, Hsieh JJ, et al. SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function. Mol Cell Biol 2000;20:2400-2410. (Pubitemid 30152048)
27. O'Rand MG, Widgren EE Identifcation of sperm antigen targets for immunocontraception: B-cell epitope analysis of Sp17. Reprod Fertil Dev 1994;6:289-296.
28. Abdullah M, Widgren EE, O'Rand MG A mammalian sperm lectin related to rat hepatocyte lectin-2/3. Purifcation from rabbit testis and identifcation as a zona binding protein. Mol Cell Biochem 1991;103:155-161.
29. Kohl B, Kohl H, Krause W, Deichert U The clinical signifcance of antisperm antibodies in infertile couples. Hum Reprod 1992;7:1384-1387. (Pubitemid 23042158)
30. Tung KS, Goldberg EH, Goldberg E Immunobiological consequence of immunization of female mice with homologous spermatozoa: induction of infertility. J Reprod Immunol 1979;1:145-158. (Pubitemid 10242042)
31. O'Rand MG, Porter JP Purifcation of rabbit spermautoantigens by preparative SDS gel electrophore-sis: Amino acid and carbohydrate content of RSA-1. Biol Reprod 1982;27:713-721. (Pubitemid 13196212)
32. O'Rand MG, Irons GP Monoclonal antibodies to rabbit sperm autoantigens. II. Inhibition of human sperm penetration of zona-free hamster eggs. Biol Reprod 1984;30:731-736.
33. Richardson RT, Yamasaki N, O'Rand MG Sequence of a rabbit sperm zona pellucida binding protein and localization during the acrosome reaction. Dev Biol 1994;165:688-701. (Pubitemid 24359828)
34. Kong M, Richardson RT, Widgren EE, O'Rand MG Sequence and localization of the mouse sperm autoantigenic protein, Sp17. Biol Reprod 1995;53:579-590.
35. Lea IA, Richardson RT, Widgren EE, O'Rand MG Cloning and sequencing of cDNAs encoding the human sperm protein, Sp17. Biochim Biophys Acta 1996;1307:263-266. (Pubitemid 26232931)
36. Dong G, Loukinova E, Smith CW, et al. Genes diferentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinoma. J Cell Biochem Suppl 1997;28-29:90-100. (Pubitemid 28246632)
37. Lea IA, Adoyo P, O'Rand MG Autoimmunogenicity of the human sperm protein Sp17in vasectomized men and identifcation of linear B cell epitopes. Fertil Steril 1997;67:355-361. (Pubitemid 27052197)
38. Lea IA, Van Lierop MJ, Widgren EE, et al. A chimeric sperm peptide induces antibodies and strain-Specific reversible infertility in mice. Biol Reprod 1998;59:527-536. (Pubitemid 28395067)
39. Wen Y, Richardson RT, O'Rand MG Processing of the sperm protein Sp17 during the acro-some reaction and characterization as a calmodulin binding protein. Dev Biol 1999;206:113-122. (Pubitemid 29100469)
40. Wen Y,Richardson RT,Widgren EE, O'Rand MG Characterization of Sp17: A ubiquitous three domain protein that binds heparin. Biochem J 2001;357:25-31. (Pubitemid 32651745)
41. Chiriva-Internati M, Wang Z, Salati E, et al. Tumor vaccine for ovarian carcinoma targeting sperm protein 17. Cancer 2002;94:2447-2453. (Pubitemid 34457127)
42. Chiriva-Internati M, Wang Z, Salati E, et al. Sperm protein 17 (Sp17) is a suitable target for im-munotherapy of multiple myeloma. Blood 2002;100:961-965. (Pubitemid 34832624)
43. Lea IA, Widgren EE, O'Rand MG Association of sperm protein 17 with A-kinase anchoring protein 3 in fagella. Reprod Biol Endocrinol 2004;2:57.
44. Grizzi F, Chiriva-Internati M, Franceschini B, et al. Immunolocalization of sperm protein 17 in human testis and ejaculated spermatozoa. J Histochem Cytochem 2003;51:1245-1248. (Pubitemid 37059537)
45. Grizzi F, Gaetani P, Franceschini B, et al. Sperm protein 17 is expressed in human nervous system tumours. BMC Cancer 2006;6:23.
46. Chiriva-Internati M, Grizzi F, Weidanz JA, et al. A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17. J Immunol Methods 2007;321:86-93. (Pubitemid 46441202)
47. Li FQ, Han YL, Liu Q, et al. Overexpression of human sperm protein 17 increases migration and decreases the chemosensitivity of human epithelial ovarian cancer cells. BMC Cancer 2009;9:323.
48. Kausar T, Ahsan A, Hasan MR, et al. Sperm protein 17 is a novel marker for predicting cisplatin response in esophageal squamous cancer cell lines. Int J Cancer 2010;126:1494-1503.
49. Chiriva-Internati M, Yu Y, Mirandola L, et al. Cancer testis antigen vaccination afords long-term protection in a murine model of ovarian cancer. PLoS One 2010;5:e10471.
50. Jones HP, Bradford MM, McRorie RA, Cormier MJ High levels of a calcium-dependent modulator protein in spermatozoa and its similarity to brain modulator protein. Biochem Biophys Res Commun 1978;82:1264-1272. (Pubitemid 8385728)
51. Adeoya-Osiguwa SA, Fraser LR. Evidence for Ca(2+)-dependent ATPase activity, stimulated by de-capacitation factor and calmodulin, in mouse sperm. Mol Reprod Dev 1996;44:111-120.
52. Sano M, Ohshima AS, Kawamura N, et al. Immunohistochemical study of calmodulin in developing mouse testis. J Exp Zool 1987;241:51-59. (Pubitemid 17223128)
53. Tash JS Protein phosphorylation: the second messenger signal transducer of fagellar motility. Cell Motil Cytoskeleton 1989;14:332-339. (Pubitemid 20001951)
54. Nakazato T, KanumaT, Tamura T, et al. Sperm protein 17 infuences the tissue-Specific malignancy of clear cell adenocarcinoma in human epithelial ovariancancer. Int J Gynecol Cancer2007;17:426-432. (Pubitemid 46426772)
55. Alper O, Bergmann-Leitner ES, Abrams S, Cho-Chung YS Apoptosis, growth arrest and suppression of invasiveness by CRE-decoy oligonucleotide in ovarian cancer cells: Protein kinase A downregula-tion and cytoplasmic export of CRE-binding proteins. Mol Cell Biochem 2001;218:55-63. (Pubitemid 32294135)
56. White FJ, Cooper DC The vicious cyclin of addiction. Nat Med 2001;7:416-417. (Pubitemid 32298541)
57. Chiriva-Internati M, Cobos E, Da Silva DM, Kast WM Sperm fbrous sheath proteins: A potential new class of target antigens for use in human therapeutic cancer vaccines. Cancer Immun 2008;8:8.
58. Chiriva-Internati M, Grizzi F, Wachtel MS, et al. Biological treatment for liver tumor and new potential biomarkers. Dig Dis Sci 2008;53:836-843. (Pubitemid 351317064)
59. Gray A, Raf AB, Chiriva-Internati M, et al. A paradigm shift in therapeutic vaccination of cancer patients: The need to apply therapeutic vaccination strategies in the preventive setting. Immunol Rev 2008;222:316-327. (Pubitemid 351430367)
60. Chiriva-Internati M, Cobos E, Kast WMAdvances inimmunotherapyofmultiple myeloma:From the discovery of tumor-associated antigens to clinical trials. Int Rev Immunol 2007;26:197-222. (Pubitemid 46897675)
61. Grizzi F, Franceschini B, Hamrick C, et al. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. J Transl Med 2007;5:3.
62. Bumm K, Grizzi F, Franceschini B, et al. Sperm protein 17 expression defnes 2 subsets of primary esthesioneuroblastoma. Hum Pathol 2005;36:1289-1293. (Pubitemid 41682284)
63. Grizzi F, Chiriva-Internati M, Franceschini B, et al. Sperm protein 17 is expressed in human somatic ciliated epithelia. J Histochem Cytochem 2004;52:549-554. (Pubitemid 38420390)
64. Dadabayev AR, Wang Z, Zhang Y, et al. Cancer immunotherapy targeting Sp17: When should the laboratory fndings be translated to the clinics? Am J Hematol 2005;80:6-11. (Pubitemid 41254261)
65. Gupta G, Sharma R, Chattopadhyay TK, et al. Clinical signifcance of sperm protein 17 expression and immunogenicity in esophageal cancer. Int J Cancer 2007;120:1739-1747. (Pubitemid 46399360)
66. Straughn Jr., JM, Shaw DR, Guerrero A, et al. Expression of sperm protein 17 (Sp17) in ovarian cancer. Int J Cancer 2004;108:805-811. (Pubitemid 38112606)
67. Kryczek I, Wei S, Zhu G, et al. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007;67:8900-8905. (Pubitemid 47437467)
68. Wei S, Kryczek I, Zou L, et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 2005;65:5020-5026. (Pubitemid 40827308)
69. Wolf D, Wolf AM, Rumpold H, et al. The expression of the regulatory T cell-Specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 2005;11:8326-8331. (Pubitemid 41746944)
70. Cannon MJ, O'Brien TJ Cellular immunotherapy for ovarian cancer. Expert Opin Biol Ter 2009;9:677-688.
71. Kryczek I, Banerjee M, Cheng P, et al. Phenotype, distribution, generation, and functional and clinical relevance of T17 cells in the human tumor environments. Blood 2009;114:1141-1149.
72. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-949. (Pubitemid 39273735)
73. Zhang Y, Wang Z, Robinson WR, Lim SH Combined real time PCR and immunohistochemical evaluation of sperm protein 17 as a cancer-testis antigen. Eur J Haematol 2004;73:280-284. (Pubitemid 39278854)